Thiogenesis Therapeutics, Corp.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Jun 9, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Aug 8, 2025 · D | Jun 9, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $125,450 | $28,964 | $-96,486 |
| Reported amount sold | $125,450 | $28,964 | $-96,486 |
| Reported investor count | — | 0 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001062993-25-013902 · Later SEC source: 0001062993-26-003123
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $28,964
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $28,964
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001062993-26-003123D · Jun 9, 2026 · BiotechnologyOffering: $28,964Sold: $28,964
Compared with 0001062993-25-013902:
- Reported offering amount: $125,450 → $28,964
- Reported amount sold: $125,450 → $28,964
- Reported investor count: Unavailable → 0
-
0001062993-25-013902D · Aug 8, 2025 · OtherOffering: $125,450Sold: $125,450